The Staying Well Study: An Open Trial of Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depression
Phase One: An Open Trial of Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depression
2 other identifiers
interventional
49
1 country
4
Brief Summary
Pregnant women with histories of depression are at high risk of depressive relapse during the perinatal period, and options for relapse prevention are limited. Mindfulness-based cognitive therapy (MBCT) has strong evidence among general populations but has not been studied among at risk pregnant women. This study is the first phase of a multi-phase project adapting MBCT for perinatal women (MBCT-PD). It is being conducted in a collaboration between the University of Colorado, Emory University, and Kaiser Permanente at Colorado and Georgia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable pregnancy
Started Nov 2008
Typical duration for not_applicable pregnancy
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 12, 2015
CompletedFirst Posted
Study publicly available on registry
March 18, 2015
CompletedApril 6, 2020
April 1, 2020
2.3 years
March 12, 2015
April 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Engagement
Engagement is operationalized in-part as class attendance, with completion is defined as attendance at a minimum of four classes, and daily home practice recorded daily as the number of times of practice and type of practice, which are classified as either formal or informal practice.
Up to 8 weeks
Client Satisfaction
Participant satisfaction will be evaluated by the CSQ-8, which is designed to yield a homogeneous estimate of general satisfaction with services. An exit interview also will be completed at 6-months postpartum.
Up to 8 weeks
MBCT-PD Adherence Scale (MBCT-PD-AS)
Treatment fidelity will be assessed to provide checks on the adequacy of treatment implementation, using the MBCT-PD Adherence Scale.
Up to 8 weeks
Depressive Relapse Status: Longitudinal Interval Follow-up Evaluation (LIFE)
Rate of depressive relapse and time to relapse will be assessed using the LIFE, which provides a retrospective assessment of relapse or recurrence based on a semi-structured interview according to DSM-IV-TR diagnostic criteria.
Up to 6 months postpartum
Change in Edinburgh Postpartum Depression Scale (EPDS)
Change in the severity of depressive symptoms will be evaluated by the Edinburgh Postpartum Depression Scale (EPDS), which is the most widely used self-report measure of antenatal and postpartum depression.
Up to 6 months postpartum
Study Arms (1)
MBCT-PD
EXPERIMENTALMindfulness-based cognitive therapy adapted for perinatal women (MBCT-PD)
Interventions
Using an iterative process, the investigators modified MBCT to include a focus on perinatal depression (MBCT-PD). The modifications took into account developmental processes associated with the perinatal period, characteristics and correlates of perinatal depression, and the physical aspects of pregnancy.
Eligibility Criteria
You may qualify if:
- Pregnant up to 32 weeks gestation
- Meeting criteria for prior depression
- Failure to meet criteria for a diagnosis of MDD in the last two months
- Available for group intervention scheduled meetings
You may not qualify if:
- Presence of schizophrenia or schizoaffective disorder
- Presence of bipolar disorder or current psychosis
- Presence of organic mental disorder or pervasive developmental delay
- Presence of current eating disorder
- Presence of current substance abuse or dependence
- Presence of antisocial, borderline, or schizotypal personality disorder
- Presence of imminent suicide or homicide risk
- Presence of any other axis I or II disorders that necessitate priority treatment not provided by the study protocol
- Women with any medical conditions that would preclude participation, including high-risk pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Colorado, Boulderlead
- Emory Universitycollaborator
- Kaiser Permanentecollaborator
- National Institute of Mental Health (NIMH)collaborator
Study Sites (4)
University of Colorado Boulder
Boulder, Colorado, 80309, United States
Kaiser Permanente Colorado
Denver, Colorado, 80234, United States
Emory University
Atlanta, Georgia, 30322, United States
Kaiser Permanente
Atlanta, Georgia, 30328, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sona Dimidjian, PhD
University of Colorado, Boulder
- PRINCIPAL INVESTIGATOR
Sherryl Goodman, PhD
Emory University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Director
Study Record Dates
First Submitted
March 12, 2015
First Posted
March 18, 2015
Study Start
November 1, 2008
Primary Completion
March 1, 2011
Study Completion
March 1, 2011
Last Updated
April 6, 2020
Record last verified: 2020-04